agilon health (AGL) Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AGL shares.
View AGL analyst ratings or view top-rated stocks.

8 Wall Street analysts have issued twelve-month price targets for agilon health's shares. Their AGL share price forecasts range from $27.00 to $35.00. On average, they anticipate the company's share price to reach $31.13 in the next twelve months. This suggests a possible upside of 51.2% from the stock's current price.
View analysts price targets for AGL or view top-rated stocks among Wall Street analysts.

agilon health's stock was trading at $16.14 at the start of the year. Since then, AGL shares have increased by 27.6% and is now trading at $20.59.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our AGL earnings forecast.

agilon health, inc. (NYSE:AGL) issued its quarterly earnings results on Tuesday, May, 9th. The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.03 by $0.01. The business had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.08 billion. agilon health had a negative trailing twelve-month return on equity of 7.98% and a negative net margin of 2.88%.

ETFs with the largest weight of agilon health (NYSE:AGL) stock in their portfolio include Adaptiv Select ETF (ADPV), Innovator IBD 50 ETF (FFTY), Invesco DWA Healthcare Momentum ETF (PTH), SPDR S&P Health Care Services ETF (XHS), Harbor Corporate Culture Leaders ETF (HAPY), Renaissance IPO ETF (IPO), AI Powered Equity ETF (AIEQ) and iShares U.S. Healthcare Providers ETF (IHF).

agilon health updated its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $4.41 billion-$4.44 billion, compared to the consensus revenue estimate of $4.33 billion.

(AGL) raised $1 billion in an IPO on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers.

agilon health trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGL."

agilon health's stock is owned by a number of retail and institutional investors. Top institutional shareholders include FMR LLC (13.19%), Wellington Management Group LLP (4.91%), BlackRock Inc. (2.10%), Brown Advisory Inc. (0.92%), Artisan Partners Limited Partnership (0.81%) and State Street Corp (0.73%). Insiders that own company stock include Benjamin Kornitzer, Benjamin Shaker, Cd&R Investment Associates Ix,, Clay Richards, Glenn Sobotka, Joan Danieley, John William Wulf, Michael L Smith, Steven Sell, Theodore Halkias and Veeral Desai.
View institutional ownership trends.

Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AGL stock can currently be purchased for approximately $20.59.

agilon health (NYSE:AGL) has a market capitalization of $8.54 billion and generates $2.71 billion in revenue each year. The company earns $-106,550,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis.

The company employs 646 workers across the globe.

The official website for the company is agilonhealth.com. The company can be reached via phone at 562-256-3800 or via email at investor.relations@agilonhealth.com.